FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

1562341000168105: Dayvigo (lemborexant 5 mg) tablet (trade product unit of use)


Status: current, Defined. Date: 31-Aug 2021. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4601631000168118 Dayvigo (lemborexant 5 mg) tablet (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4601641000168110 Dayvigo 5 mg tablet en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dayvigo 5 mg tablet Is a Dayvigo true Inferred relationship Some
Dayvigo 5 mg tablet Is a lemborexant 5 mg tablet true Inferred relationship Some
Dayvigo 5 mg tablet Is a trade product unit of use true Inferred relationship Some
Dayvigo 5 mg tablet has manufactured dose form tablet true Inferred relationship Some
Dayvigo 5 mg tablet has Australian BoSS lemborexant true Inferred relationship Some 1110233371
Dayvigo 5 mg tablet has intended active ingredient lemborexant true Inferred relationship Some 1110233371
Dayvigo 5 mg tablet has unit of use tablet true Inferred relationship Some 1076427401

Inbound Relationships Type Active Source Characteristic Refinability Group
Dayvigo 5 mg tablet, 3 has TPUU True Dayvigo 5 mg tablet Inferred relationship Some 406657762
Dayvigo 5 mg tablet, 3, blister pack has TPUU True Dayvigo 5 mg tablet Inferred relationship Some 674162550
Dayvigo 5 mg tablet, 28 has TPUU True Dayvigo 5 mg tablet Inferred relationship Some 269787649
Dayvigo 5 mg tablet, 28, blister pack has TPUU True Dayvigo 5 mg tablet Inferred relationship Some 1408572762

Reference Sets

Black Triangle Scheme reference set

Trade product unit of use reference set

Back to Start